HomeXSPRAY • STO
add
XSpray Pharma AB (publ)
Previous close
kr 41.95
Day range
kr 42.00 - kr 43.85
Year range
kr 28.10 - kr 54.80
Market cap
1.08B SEK
Avg Volume
13.52K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 27.42M | -50.59% |
Net income | -54.50M | 1.31% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -24.97M | 53.98% |
Effective tax rate | 0.03% | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 166.30M | 38.39% |
Total assets | 765.26M | 30.72% |
Total liabilities | 71.85M | 144.30% |
Total equity | 693.41M | — |
Shares outstanding | 31.25M | — |
Price to book | 1.89 | — |
Return on assets | -9.33% | — |
Return on capital | -9.85% | — |
Cash Flow
Net change in cash
(SEK) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -54.50M | 1.31% |
Cash from operations | -32.63M | 6.79% |
Cash from investing | -20.73M | 29.69% |
Cash from financing | 87.48M | -7.73% |
Net change in cash | 33.82M | 11.51% |
Free cash flow | -10.41M | 81.11% |
About
Founded
2003
Website
Employees
26